Although MEK/ERK-pathway mechanisms play a crucial roles in mediating brain injury after ischemia and reperfusion, and inhibiting this pathway can reduce the infarct size [17,28], we provide direct evidence supporting an explanation for some of the events related to the focal pathology of cerebral ischemia [29]. The gene discussed is MAP2K7; the disease is brain ischemia.